- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Aug 9, 2022 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Aug 9, 2022 | T-604-19 | M | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Ottawa | 1 d |
| Aug 9, 2022 | T-604-19 | TMC | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Ottawa | 1 d |
| Aug 9, 2022 | T-512-20 | M | 2660722 Ontario Inc. Et Al. V. Vanpak Limited Et Al. (unknown) | Toronto | 4 h |
| Aug 9, 2022 | T-604-19 | MED | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Calgary | 6 h |
| Aug 10, 2022 | T-1062-21 | CMC | Millennium Funding, Inc. Et Al. V. Bell Canada Et Al. (Copyright) | Toronto | 30 m |
| Aug 10, 2022 | T-1241-22 | CMC | Bayer Inc. Et Al V. Bgp Pharma Ulc Et Al (Patent - Aflibercept*) | Ottawa | 30 m |
| Aug 10, 2022 | T-1482-22 | CMC | Bayer Inc. Et Al. V. Bgp Pharma Ulc D.b.a. Viatris Canada Et Al. (Patent - Aflibercept*) | Ottawa | 30 m |
| Aug 11, 2022 | T-1226-21 | CMC | 2660722 Ontario Inc. Et Al. V. Ss Group Holding Limited (unknown) | Toronto | 30 m |
| Aug 11, 2022 | T-1168-21 | CMC | Dr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (Patent) | Toronto | 1 h |
| Aug 11, 2022 | T-607-21 | CMC | Apotex Inc. V. Janssen Inc. Et Al. (Patent - Abiraterone*) | Toronto | 1 h |
| Aug 11, 2022 | T-732-22 | CMC | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 h |
| Aug 11, 2022 | T-336-21 | CMC | Joseph Tomelleri V. Whitefish Watershed Association (Copyright) | Ottawa | 30 m |
| Aug 11, 2022 | T-343-20 | CMC | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 30 m |
| Aug 11, 2022 | T-1097-20 | M | Eurofase Inc. V. Crystal World Inc. C/o/b Cwi Lighting (unknown) | Toronto | 1 h |
| Aug 15, 2022 | T-326-18 | MED | The Province Of Alberta Et Al V. The Canadian Copyright Licensing Agency (Copyright) | Ottawa | 1 d |
| Aug 15, 2022 | T-604-19 | T | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Calgary | 15 d |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Aug 8, 2022 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 19.6 d |
| Aug 15, 2022 | T-604-19 | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Calgary | 15 d |
| Sep 12, 2022 | T-202-17 | Travel Leaders Group, Llc V. 204293 Ontario Inc. Dba Travel Leaders (Trade Mark) | Toronto | 10 d |
| Sep 15, 2022 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 1.7 d |
| Sep 21, 2022 | T-1049-18 | Re/max, Llc V. Save Max Real Estate, Inc. Et Al. (Trade Mark) | Vancouver | 13 d |
| Oct 17, 2022 | T-1790-17 | Valley Blades Ltd. V. Usinage Pro-24 Inc. C/o/b As Nordik Blades (Patent) | Ottawa | 7 d |
| Oct 17, 2022 | T-416-19 | Usinage Pro-24 Inc. V. Valley Blades Ltd. (Patent) | Ottawa | 7 d |
| Oct 17, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 15 d |
| Oct 31, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 9 d |
| Nov 9, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 2 d |
| Nov 14, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-1531-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-1533-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-1252-19 | Modpro Containers Ltd Et Al. V. Tangle Pools Et Al. (unknown) | Vancouver | 5 d |
| Nov 14, 2022 | T-1686-18 | Wheel Monitor Inc. V. Cleral Inc. Et Al (Patent) | Toronto | 10 d |
| Nov 21, 2022 | T-2060-19 | 9209-6601 Quã?bec Inc. C. Rep Solution Interactive Inc. (Trade Mark) | Montréal | 8 d |
| Dec 5, 2022 | T-668-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*) | Toronto | 10 d |
| Dec 5, 2022 | T-1213-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*) | Toronto | 10 d |
| Dec 5, 2022 | T-919-21 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 7 d |
| Dec 7, 2022 | T-1533-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 3 d |
| Dec 7, 2022 | T-1531-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 3 d |
| Dec 15, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 19, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Jan 9, 2023 | T-1007-20 | Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. Et Al (Patent) | Toronto | 14 d |
| Feb 13, 2023 | T-512-20 | 2660722 Ontario Inc. Et Al. V. Vanpak Limited Et Al. (unknown) | To be determined (TrialJA) | 10 d |
| Feb 20, 2023 | T-374-21 | Vidã?otron Ltã?e Et Al C. Technologies Konek Inc. Et Al (Copyright) | Montréal | 8 d |
| Feb 20, 2023 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 7 d |
| Feb 27, 2023 | T-788-21 | Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*) | Toronto | 15 d |
| Mar 3, 2023 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 1 d |
| Mar 20, 2023 | T-703-20 | Kaira District Coop Milk Producers Union Ltd Et Al V Amul Canada Ltd Et Al (Trade Mark) | Toronto | 5 d |
| Apr 11, 2023 | T-711-20 | Bell Canada V. Skychoice Communications Inc. (Trade Mark) | Toronto | 8 d |
| Apr 17, 2023 | T-609-20 | Wanakome Inc. V. Eric Martin Et Al. (Trade Mark) | Montréal | 10 d |
| May 8, 2023 | T-1924-17 | Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright) | Toronto | 10 d |
| Jun 5, 2023 | T-1966-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 8 d |
| Jun 5, 2023 | T-379-21 | Molo Design, Ltd. V. Chanel Canada Ulc Et Al. (Patent) | Montréal | 10 d |
| Jun 5, 2023 | T-1168-21 | Dr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (Patent) | Toronto | 10 d |
| Jun 19, 2023 | T-1966-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 2 d |
| Jun 19, 2023 | T-607-21 | Apotex Inc. V. Janssen Inc. Et Al. (Patent - Abiraterone*) | Toronto | 10 d |
| Jul 10, 2023 | T-1472-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*) | Toronto | 15 d |
| Jul 10, 2023 | T-1475-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*) | Toronto | 15 d |
| Sep 11, 2023 | T-1962-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 5 d |
| Sep 11, 2023 | T-1994-21 | Allergan, Inc. Et Al. V. Juno Pharmaceuticals Corp. (Patent - Bimatoprost*) | Toronto | 10 d |
| Sep 21, 2023 | T-1962-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 2 d |
| Sep 25, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 2 d |
| Oct 3, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 4 d |
| Oct 3, 2023 | T-15-22 | Boehringer Ingleheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent - Linagliptin*) | Toronto | 16 d |
| Oct 10, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 4 d |
| Oct 16, 2023 | T-214-22 | Bristol-myers Squibb Canada Co. Et Al. V. Jamp Pharma Corporation (Patent - Apixaban*) | Toronto | 10 d |
| Oct 16, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | To be determined (TrialJA) | 10 d |
| Oct 16, 2023 | T-653-21 | Apotex Inc. V. Servier Canada Inc. (Patent - Perindopril*) | Toronto | 10 d |
| Oct 30, 2023 | T-192-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Teva Canada Limited (Patent - Sacubitril*) | Ottawa | 10 d |
| Nov 9, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | To be determined (TrialJA) | 2 d |
| Nov 20, 2023 | T-1386-21 | Jcai Inc. V. Wiseleap Solutions Inc. Et Al (Patent) | To be determined (TrialJA) | 12 d |
| Jan 22, 2024 | T-971-22 | Lundbeck Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Vortioxetine*) | Toronto | 10 d |
| Mar 11, 2024 | T-1176-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1175-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent) | Toronto | 13 d |
| Mar 11, 2024 | T-1178-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1181-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1187-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1188-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Apr 4, 2024 | T-1175-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent) | Toronto | 2 d |
| Apr 4, 2024 | T-1176-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1178-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1181-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1187-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1188-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Aug 8, 2022 | T-349-21 | Cheung's Bakery Products Ltd. V. Easywin Ltd. | Trade Mark Opposition | Vancouver | 1 d |
| Aug 22, 2022 | T-428-22 | Oakley, Inc. V. Osler, Hoskin & Harcourt Llp | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Sep 13, 2022 | T-1191-21 | J-tech Digital, Inc. V. Smart & Biggar Llp | Trade Mark - Appeal of a decision of the Registrar | Montréal | 3 h |
| Sep 20, 2022 | T-1561-20 | G N R Travel Centre Ltd. V. Cwi, Inc. Et Al. | Trade Mark - Appeal of a decision of the Registrar | Winnipeg | 1 d |
| Oct 31, 2022 | T-1752-21 | The Coca-cola Company V. Agc | Patent - Appeal of a Decision of Commissioner | Toronto | 1 d |
| Nov 2, 2022 | T-141-22 | The Spirit Bear Coffee Company Inc. V. Kitasoo Band Council | S. 18.1 Application for Judicial Review | Vancouver | 1.3 d |
| Dec 8, 2022 | T-1172-21 | Standard International Management Llc V. Asia Standard Management Services L | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Sep 14, 2022 | A-267-20 | Janssen Inc. Et Al V. Apotex Inc. - Abiraterone* | Appeal (S.27 - Interloc.) - Patent Act [from T-84-19 - Patented Medicines (NOC) Regulations [Actions]] | Ottawa | 1 d |
| Sep 14, 2022 | A-36-21 | Janssen Inc. Et Al V. Pharmascience Inc. - Abiraterone* | Appeal (S.27 - Final) - Patent Act [from T-182-19 - Patent Infringement] | Ottawa | 1 d |
| Sep 14, 2022 | A-37-21 | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Abiraterone* | Appeal (S.27 - Final) - Patent Act [from T-978-19 - Patent Infringement] | Ottawa | 1 d |
| Sep 14, 2022 | A-38-21 | Janssen Inc. Et Al V. Apotex Inc. - Abiraterone* | Appeal (S.27 - Final) - Patent Act [from T-84-19 - Patented Medicines (NOC) Regulations [Actions]] | Ottawa | 1 d |
| Sep 15, 2022 | A-249-21 | Alliance Nationale De L'industrie Musicale C. Crtc | Appeal (S.27 - Interloc.) - Others [from T-1480-19 - Copyright Infringement [Actions]] | Montréal | 4 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.